Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLGN CollPlant Biotechnologies	$2.55 -3.8%	$3.44	$2.54 ▼ $6.75	$29.21M	1.07	10,606 shs	3,203 shs
INFU InfuSystem	$5.47 -9.7%	$7.23	$5.29 ▼ $9.97	$114.92M	1.75	77,985 shs	64,502 shs
KRMD KORU Medical Systems	$2.59 -0.8%	$3.70	$2.05 ▼ $5.05	$119.03M	0.74	136,581 shs	118,014 shs
STIM Neuronetics	$3.77 -5.8%	$4.03	$0.52 ▼ $5.92	$114.41M	2.07	627,622 shs	1.72 million shs

7 Top Nuclear Stocks To Buy Now

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLGN CollPlant Biotechnologies	-3.77%	-21.17%	-27.35%	-28.57%	-53.13%
INFU InfuSystem	-9.74%	-6.17%	-30.85%	-32.80%	-40.86%
KRMD KORU Medical Systems	-0.77%	-7.83%	-27.65%	-34.26%	+13.60%
STIM Neuronetics	-5.75%	-22.43%	-18.57%	+154.73%	-21.46%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLGN CollPlant Biotechnologies	2.8487 of 5 stars	3.7	5.0	2.6	0.0	0.6
INFU InfuSystem	1.9788 of 5 stars	2.0	0.0	2.8	2.5	1.9
KRMD KORU Medical Systems	2.8807 of 5 stars	3.5	3.0	2.7	2.5	0.6
STIM Neuronetics	2.2462 of 5 stars	3.3	2.0	2.9	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLGN CollPlant Biotechnologies	3.33	Buy	$12.50	390.20% Upside
INFU InfuSystem	4.00	Strong Buy	$13.00	137.66% Upside
KRMD KORU Medical Systems	3.00	Buy	$4.70	81.47% Upside
STIM Neuronetics	2.67	Moderate Buy	$5.50	45.89% Upside

Current Analyst Ratings Breakdown

Latest CLGN, STIM, KRMD, and INFU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/27/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00
3/18/2025	INFU InfuSystem	Sidoti Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/13/2025	KRMD KORU Medical Systems	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/5/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$5.00 ➝ $8.00
2/14/2025	KRMD KORU Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$4.50 ➝ $4.50
2/12/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00
2/4/2025	CLGN CollPlant Biotechnologies	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$14.00 ➝ $14.00
1/17/2025	KRMD KORU Medical Systems	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$5.00 ➝ $6.00
1/14/2025	KRMD KORU Medical Systems	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$4.00 ➝ $5.00

(Data available from 3/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLGN CollPlant Biotechnologies	$650K	44.94	N/A	N/A	$2.47 per share	1.03
INFU InfuSystem	$134.86M	0.85	$0.43 per share	12.79	$2.47 per share	2.21
KRMD KORU Medical Systems	$33.65M	3.54	N/A	N/A	$0.45 per share	5.76
STIM Neuronetics	$74.89M	1.53	N/A	N/A	$1.18 per share	3.19

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLGN CollPlant Biotechnologies	-$7.02M	-$1.54	N/A	N/A	N/A	-2,680.00%	-77.05%	-61.43%	5/27/2025 (Estimated)
INFU InfuSystem	$870K	$0.10	91.18	17.65	N/A	1.12%	2.78%	1.41%	N/A
KRMD KORU Medical Systems	-$13.74M	-$0.12	N/A	N/A	N/A	-37.42%	-24.60%	-16.87%	N/A
STIM Neuronetics	-$30.19M	-$1.37	N/A	N/A	N/A	-50.09%	-141.24%	-32.77%	5/6/2025 (Estimated)

Latest CLGN, STIM, KRMD, and INFU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/3/2025	N/A	CLGN CollPlant Biotechnologies	-$0.42	N/A	N/A	N/A	$0.36 million	N/A
3/26/2025	Q4	CLGN CollPlant Biotechnologies	-$0.42	-$0.34	+$0.08	-$0.34	$0.36 million	$0.17 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLGN CollPlant Biotechnologies	N/A	N/A	N/A	N/A	N/A
INFU InfuSystem	N/A	N/A	N/A	N/A	N/A
KRMD KORU Medical Systems	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLGN CollPlant Biotechnologies	N/A	5.38	5.23
INFU InfuSystem	0.50	1.98	1.59
KRMD KORU Medical Systems	0.01	2.99	2.37
STIM Neuronetics	4.90	3.16	2.87

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLGN CollPlant Biotechnologies	21.69%
INFU InfuSystem	71.13%
KRMD KORU Medical Systems	58.60%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
CLGN CollPlant Biotechnologies	9.60%
INFU InfuSystem	10.20%
KRMD KORU Medical Systems	25.60%
STIM Neuronetics	9.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLGN CollPlant Biotechnologies	70	11.46 million	10.36 million	Optionable
INFU InfuSystem	410	21.01 million	19.10 million	Optionable
KRMD KORU Medical Systems	80	45.96 million	34.10 million	Optionable
STIM Neuronetics	180	30.35 million	27.37 million	Optionable

CLGN, STIM, KRMD, and INFU Headlines

Recent News About These Companies

William Blair Keeps Their Hold Rating on Neuronetics (STIM)

March 28 at 10:19 PM | markets.businessinsider.com

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

March 27 at 4:30 PM | globenewswire.com

This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here

March 25, 2025 | msn.com

While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership

March 23, 2025 | finance.yahoo.com

Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet

March 18, 2025 | zacks.com

Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Increase in Short Interest

March 18, 2025 | marketbeat.com

William Blair Forecasts Increased Earnings for Neuronetics

March 8, 2025 | marketbeat.com

Neuronetics (NASDAQ:STIM) Given New $8.00 Price Target at Canaccord Genuity Group

March 6, 2025 | marketbeat.com

Neuronetics price target raised to $8 from $5 at Canaccord

March 5, 2025 | markets.businessinsider.com

Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript

March 5, 2025 | msn.com

Neuronetics price target raised to $7 from $3 at Citizens JMP

March 5, 2025 | markets.businessinsider.com

Neuronetics Shares Rise in Premarket on Rosy Growth Outlook

March 4, 2025 | marketwatch.com

Neuronetics reports Q4 EPS (33c), consensus (24c)

March 4, 2025 | markets.businessinsider.com

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

March 4, 2025 | seekingalpha.com

Neuronetics (NASDAQ:STIM) Issues Earnings Results, Misses Expectations By $0.07 EPS

March 4, 2025 | marketbeat.com

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

March 4, 2025 | globenewswire.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 3, 2025 | globenewswire.com

Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now

February 23, 2025 | msn.com

Neuronetics to Announce Q4 2024 Results on March 4, 2025

February 22, 2025 | msn.com

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

February 21, 2025 | markets.businessinsider.com

Stephen Furlong Sells 17,307 Shares of Neuronetics, Inc. (NASDAQ:STIM) Stock

February 19, 2025 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLGN, STIM, KRMD, and INFU Company Descriptions

CollPlant Biotechnologies NASDAQ:CLGN

$2.55 -0.10 (-3.77%)

Closing price 03/28/2025 03:58 PM Eastern

Extended Trading

$2.58 +0.03 (+0.98%)

As of 03/28/2025 06:25 PM Eastern

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

InfuSystem NYSE:INFU

$5.47 -0.59 (-9.74%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$5.52 +0.04 (+0.82%)

As of 03/28/2025 04:23 PM Eastern

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

KORU Medical Systems NASDAQ:KRMD

$2.59 -0.02 (-0.80%)

As of 03/28/2025 04:00 PM Eastern

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Neuronetics NASDAQ:STIM

$3.77 -0.23 (-5.75%)

Closing price 03/28/2025 04:00 PM Eastern

Extended Trading

$3.76 0.00 (-0.13%)

As of 03/28/2025 07:07 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time